-
drug
a chemical used to diagnose, treat, or prevent disease
-
pharmacology
the study of drugs and their interactions with the body
-
assay
a test that determines the amount and purity of a given chemical in a preparation in a laboratory
-
Schedule I drug
high abuse potential; no accepted medical indications
-
Schedule II drug
high abuse potential; accepted medical indications
-
Schedule III drug
less abuse potential than I or II, accepted medical indications
-
Schedule IV drug
low abuse potential
-
Schedule V drug
low abuse potential
-
bioequivalence
relative therapeutic effectiveness of chemically equivalent drugs
-
bioassay
test to ascertain a drug's availability in a biological world
-
Phase I of Human drug studies
determine the pharmokinetics, toxicity, and safe dose in humans (tested on healthy individuals)
-
Phase II of human drug testing
determine the pharmokinetics, toxicity, and safe dose in humans (tested on indiviuals with the disease to be treated)
-
Phase III of human drug testing
use to refine therapeutic dose and to collect relevant data on side effects
once Phase III is complete, the manufacturer files a New Drug Application with the FDA
-
Phase IV of human drug testing
postmarketing analysis during conditional approval
-
Six Rights of med administration
- right patient
- right dose
- right medication
- right route
- right time
- right documentation
-
dose packaging
medications packages that contain a single dose for a single patient
-
teratonic drug
medication that may deform or kill the fetus
-
free drug availability
proportion of a drug available in the body to cause either desired or undesired effects
-
pharmacokinetics
- how a drug is absorbed, distributed, metabolized (biotransformed), and excreted
- how drugs are transported into and out of the body
-
pharmacodynamics
how a drug interacts with the body to cause its effects
-
active transport
requires the use of energy to move a substance
-
carrier-mediated diffusion/ facilitated transport
process in which carrier proteins transport large molecules across the cell membrane
-
passive transport
movement of a substance without the use of energy
-
diffusion
movement of a solute from an area of higher concentration to an area of lower concentration
-
osmosis
movement of solvent in a solution from an area of lower solute concentration to an area of higher solute concentration
-
filtration
movement of molecules across a membrane from an area of higher pressure to an area of lower pressure
-
ionize
to become electrically charged (polar)
-
bioavailability
amount of a drug that is still active after it reaches its target tissue
-
blood-brain barrier
tight junctions in the capillary endothelial cells in the central nervous system vasculature through which only non-protein bound, highly lipid soluble drugs can pass
-
placental barrier
biochemical barrier at the maternal/ fetal interfae that restricts certain molecules
-
metabolism
the body's breaking down of chemicals into different chemicals
-
biotransformation
metabolism of drugs
-
prodrug (parent drug)
medication that is not active when administered, but whose biotransformation converts it into active metabolites
-
first-pass effect
the liver's partial or complete inactivation of a drug before it reaches the systemic circulation
-
oxidation
the loss of hydrogen atoms or the acceptance of an oxygen atom (increase positive charge/ lessens negative charge)
-
hydrolysis
the breakage of a chemical bond by adding water
-
enteral route
delivery of a medication through the GI tract
-
parenteral route
delivery of a medication outside of the GI tract
-
receptor
specialized protein that combines with a drug resulting in a biochemical effect
-
affinity
force of attraction between a drug and a receptor
-
efficacy
a drug's ability to cause the expected response
-
second messenger
a chemical that participates in complex cascading reactions that eventually cause a drug's desired effect
-
down-regulation
binding of a drug or homone to a target cell receptor that causes the number of receptors to decrease
-
up-regulation
binding of a drug or homone to a target cell receptor that causes the number of receptors to increase
-
agonist
drug that binds to a receptor and causes it to initiate the expected response
-
antagonist
drug that binds to a receptor that does not cause it to initiate the expected response
-
agonist-antagonist (partial agonist)
|
|